Compound Dihydroartemisinin Tablets

This product is a compound antimalarial drug composed of dihydroartemisinin, piperaquine phosphate, and trimethoprim. Dihydroartemisinin has a strong killing effect on the asexual body of Plasmodium, and can quickly kill Plasmodium, thereby quickly controlling symptoms; the antimalarial effect of piperaquine phosphate is similar to that of chloroquine. After oral absorption, it is stored in the liver and then slowly released into the blood. It has a long-lasting effect and can be used for the prevention and treatment of malaria symptoms; trimethoprim has the effect of inhibiting dihydrofolate reductase. It binds to the dihydrofolate reductase of Plasmodium, interferes with its purine synthesis, and thus inhibits the growth of Plasmodium. The results of pharmacological experiments show that the three-drug formula has a synergistic effect and can delay the development of drug resistance in Plasmodium.

Main ingredients: This product contains dihydroartemisinin, piperaquine phosphate and trimethoprim.

This product is a film-coated tablet, which appears off-white or light yellow after removing the coating.

This product is used to treat falciparum malaria and vivax malaria.

Oral. The total amount of 8 tablets per course of treatment for adults, the first dose, 2 tablets each at the 6th hour, 24th hour and 32nd hour. Dosage for different age groups: Take a red tablet (low-dose primaquine) with the first dose, 1 tablet for those over 11 years old, half a tablet for those 7-10 years old, 1/3 tablet for those 3-6 years old, and 1/6 tablet for those 1-2 years old.

The main adverse reactions of this product are as follows: 1. Gastrointestinal reactions: such as nausea, vomiting, loss of appetite, abdominal pain, diarrhea, salivation, etc.; 2. Nervous system: such as dizziness, headache, tinnitus, fatigue, poor sleep, etc.; 3. Allergic reactions: skin itching, rash, etc.; 4. Laboratory abnormalities: such as transient decrease in peripheral red blood cells, transient increase in SGPT and SGOT, decrease in white blood cells and platelets, etc.

1. People who are allergic to any of the ingredients in this product; 2. Pregnant women; 3. Patients with severe liver and kidney diseases, blood diseases (such as leukopenia, thrombocytopenia, etc.).

Precautions for children: Not yet clear. Precautions for pregnancy and lactation: Not yet clear. Precautions for the elderly: Not yet clear.

Drug interactions may occur if used with other drugs. Please consult your doctor or pharmacist for details.

seal.

Dihydroartemisinin 32mg, piperaquine phosphate 320mg, trimethoprim 90mg

24 months

Chongqing Tonghe Pharmaceutical Co., Ltd.

• Founded in:

  1998-07-30

• Address:

  Baishatuo, Mingshan Street, Fengdu County, Chongqing

• Tax NO.:

  9150023020875344X9

• Registered Funds:

  10 million yuan

• Email:

  Log in to view